L

Liaoning Cheng Da Co Ltd
SSE:600739

Watchlist Manager
Liaoning Cheng Da Co Ltd
SSE:600739
Watchlist
Price: 9.59 CNY -0.72% Market Closed
Market Cap: 14.7B CNY
Have any thoughts about
Liaoning Cheng Da Co Ltd?
Write Note

Net Margin
Liaoning Cheng Da Co Ltd

3.1%
Current
7%
Average
2.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.1%
=
Net Income
346.3m
/
Revenue
11.3B

Net Margin Across Competitors

Country CN
Market Cap 14.7B CNY
Net Margin
3%
Country US
Market Cap 16.2B USD
Net Margin
5%
Country US
Market Cap 12.4B USD
Net Margin
8%
Country US
Market Cap 9.5B USD
Net Margin
5%
Country BE
Market Cap 8.2B EUR
Net Margin
5%
Country ZA
Market Cap 7.8B Zac
Net Margin
5%
Country UK
Market Cap 3.1B GBP
Net Margin
2%
Country CN
Market Cap 24.5B CNY
Net Margin
1%
Country CN
Market Cap 18.3B CNY
Net Margin
12%
Country HK
Market Cap 15.4B HKD
Net Margin
6%
Country CN
Market Cap 14.4B CNY
Net Margin
3%
No Stocks Found

Liaoning Cheng Da Co Ltd
Glance View

Market Cap
14.6B CNY
Industry
Distributors

Liaoning Cheng Da Co Ltd stands as a significant player in the landscape of Chinese conglomerates, weaving a diverse portfolio that strategically aligns with the economic growth patterns of the region. Founded in the bustling province of Liaoning, the company epitomizes a model of diversified investment, underpinning its operations with a well-considered spread across various sectors. Initially, it carved a niche in the trading business, leveraging the abundant natural resources and industrial outputs of its home province to build a steady stream of revenue. This foundation allowed Cheng Da to expand into pharmaceuticals, real estate, and financial investments, each segment contributing distinctively to the company’s overall robustness. Cheng Da’s pharmaceutical business has emerged as a cornerstone, thriving amidst the rising demand for healthcare products in China. This arm of the company is particularly adept in leveraging advanced research methodologies combined with traditional Chinese medicine, thus creating a distinctive edge in both domestic and international markets. Meanwhile, its real estate ventures capably ride the wave of urbanization in China, focusing on premium residential and commercial properties, enhancing the urban landscape while adding to its financial metrics. By sitting at the crossroads of critical sectoral developments and maintaining a keen eye on expansive opportunities, Liaoning Cheng Da Co Ltd astutely navigates the intricate dance of market dynamics, thus cementing its place as a formidable entity in the economic engine of China.

Intrinsic Value
14.52 CNY
Undervaluation 34%
Intrinsic Value
Price
L
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.1%
=
Net Income
346.3m
/
Revenue
11.3B
What is the Net Margin of Liaoning Cheng Da Co Ltd?

Based on Liaoning Cheng Da Co Ltd's most recent financial statements, the company has Net Margin of 3.1%.